Jiangbo Pharmaceuticals, Inc. (JGBO.OB) Remains Confident in Previously Issued Guidance for Fiscal 2009
Today, Jiangbo Pharmaceuticals, Inc., a U.S. pharmaceutical company with its primary operations in China, reaffirmed its previously announced guidance for fiscal year 2009. According to the press release, the company anticipates meeting or exceeding its goals of $111 to $116 million in revenue and operating income of $40 to $43 million for the fiscal year ending June 30, 2009. "We plan to report our annual results for the fiscal year 2009 by the end of this month and are pleased to reaffirm we are on track to achieve our financial goals," stated Mr. Wubo Cao, Chief Executive Officer of Jiangbo.…